// App-Quantinova.ai

DOP048 : PROFILE trial: predicting outcomes for Crohn's disease using a molecular biomarker

Researchers

Presenter

  • J. Lee

Principal Investigators

  • D. Biasci

  • N. Noor

  • E. McKinney

  • T. Ahmad

  • N. Lewis

  • A. Hart

  • P. Lyons

  • M. Parkes

  • K. Smith

Medical Centers

  • University of Cambridge School of Clinical Medicine, United Kingdom

  • Addenbrooke's Hospital NHS Trust, Department of Gastroenterology, Cambridge, United Kingdom

  • University of Exeter, Exeter IBD and Pharmacogenetics Research Group, Exeter, United Kingdom

  • Nottingham University Hospitals, Physiotherapy, Nottingham, United Kingdom

  • St Mark's Hospital, Inflammatory Bowel Disease Unit, London, United Kingdom

  • Imperial College London, Faculty of Medicine- Department of Surgery & Cancer, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • Cluster of differentiation 8A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved